摘要
目的探讨肾细胞癌（RCC）、肾错构瘤（AML）保留肾单位手术（NSS）的可能性和疗效。方法对30例肾癌15例肾AML患者行47人次保留肾单位的手术治疗，肾癌瘤体直径平均2．83cm，肾AML瘤体平均直径5．7cm。无症状22例，有症状23例。单侧肾癌28例，肾AML13例；双侧肾癌1例，肾AML2例，术后孤立肾肾癌1例。对侧肾功能正常37例，对侧肾有病变或潜在病变8例。全部通过电话对其随访。结果45例手术均成功。术后随访平均63个月，除1例肾癌术后16个月因肺癌广泛转移而死亡外，2例肾AML行选择性动脉栓塞（SAE），余均无瘤生存至今。结论肾癌、肾AML保留肾单位的手术治疗在适应证下是安全有效的。
Objectives To investigate the possibility and the clinical effects of nephron - sparing surgery （NSS） for RCC and AML. Methods NSS was performed for 30 patients with RCC and 15 patients with AML . The mean diameter of tumors was 2.83 cm in RCC and 5.70cm in twenty two. No - symptom 23. cases were without symptom with symptoms,23 cases of which there were 41 patients with unilateral tumor, 3 patients with bilateral tumors, and 1 patient with tumor in a solitary kidney. Thirty seven patients with a normal contralateral kidney, and 8 cases with unilateral tumor and a compromised contralateral kidney. They had been following up to now by telephone. Results All operations were successful. Mean 63 months follow - up showed that 42 patients had been living without tumors, 1 patient died of metastasis and 2 patients with AML were treated with SAE. Conclusions NSS is an effective and safe procedure for patients with RCC and AML under fit circumstance.
出处
《国际泌尿系统杂志》
2007年第2期145-147,共3页
International Journal of Urology and Nephrology
关键词
肾肿瘤
错构瘤
肾单位
Kidney Neoplasmas
Hamartoma
Nephrons
